ESPR
NASDAQ · Pharmaceuticals
Esperion Therapeutics Inc
$3.15
-0.02 (-0.63%)
Open$3.17
Previous Close$3.17
Day High$3.17
Day Low$3.15
52W High$4.18
52W Low$0.95
Volume—
Avg Volume10.54M
Market Cap811.73M
P/E Ratio—
EPS$-0.06
SectorPharmaceuticals
Analyst Ratings
Sell
11 analysts
Price Target
+500.3% upside
Current
$3.15
$3.15
Target
$18.91
$18.91
$12.50
$18.91 avg
$21.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 499.77M | 285.94M | 122.60M |
| Net Income | -28,114,342 | -14,477,004 | 36.77M |
| Profit Margin | -5.6% | -5.4% | 30.0% |
| EBITDA | 74.86M | 40.69M | 61.92M |
| Free Cash Flow | — | — | 30.39M |
| Rev Growth | +74.8% | +74.8% | -8.9% |
| Debt/Equity | — | — | 0.54 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |